213 related articles for article (PubMed ID: 12845645)
1. Histogenesis of hepatoid adenocarcinoma of the stomach: molecular evidence of identical origin with coexistent tubular adenocarcinoma.
Akiyama S; Tamura G; Endoh Y; Fukushima N; Ichihara Y; Aizawa K; Kawata S; Motoyama T
Int J Cancer; 2003 Sep; 106(4):510-515. PubMed ID: 12845645
[TBL] [Abstract][Full Text] [Related]
2. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
[TBL] [Abstract][Full Text] [Related]
3. Primary hepatocellular carcinoma and hepatoid adenocarcinoma of the stomach with liver metastasis: an unusual association.
Morinaga S; Takahashi Y
Jpn J Clin Oncol; 1996 Aug; 26(4):258-63. PubMed ID: 8765186
[TBL] [Abstract][Full Text] [Related]
4. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
[TBL] [Abstract][Full Text] [Related]
5. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA.
Supriatna Y; Kishimoto T; Uno T; Nagai Y; Ishikura H
Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach.
Sentani K; Oue N; Sakamoto N; Arihiro K; Aoyagi K; Sasaki H; Yasui W
Mod Pathol; 2008 Apr; 21(4):464-75. PubMed ID: 18204429
[TBL] [Abstract][Full Text] [Related]
7. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics, diagnosis and treatment of hepatoid adenocarcinoma of the stomach].
Yang CK; Zhao WJ; Dai QB; Zhang HH; Zheng W
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):245-8. PubMed ID: 17520383
[TBL] [Abstract][Full Text] [Related]
9. Further evidence of hepatic transdifferentiation in hepatoid adenocarcinomas of the stomach: quantitative analysis of mRNA for albumin and hepatocyte nuclear factor-4alpha.
Yano T; Kishimoto T; Tomaru U; Kawarada Y; Kato H; Yoshiki T; Ishikura H
Pathology; 2003 Feb; 35(1):75-8. PubMed ID: 12701690
[TBL] [Abstract][Full Text] [Related]
10. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
[TBL] [Abstract][Full Text] [Related]
11. [Pathological study of hepatoid gastric adenocarcinomas].
Song H; Li S; Yang Y
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):56-9. PubMed ID: 7544725
[TBL] [Abstract][Full Text] [Related]
12. [A case of hepatoid adenocarcinoma of the stomach].
Li XZ
Zhonghua Zhong Liu Za Zhi; 1989 Jan; 11(1):74-5. PubMed ID: 2476287
[TBL] [Abstract][Full Text] [Related]
13. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
[TBL] [Abstract][Full Text] [Related]
14. Different characteristics of hepatoid and non-hepatoid alpha-fetoprotein-producing gastric carcinomas: an experimental study using xenografted tumors.
Aizawa K; Motoyama T; Suzuki S; Tanaka N; Yabusaki H; Tanaka S; Muto I; Tanaka O; Hatakeyama K
Int J Cancer; 1994 Aug; 58(3):430-5. PubMed ID: 7519587
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of ATP binding cassette (ABC) family of drug transporters in gastric hepatoid adenocarcinomas.
Kamata S; Kishimoto T; Kobayashi S; Miyazaki M
Histopathology; 2008 May; 52(6):747-54. PubMed ID: 18439156
[TBL] [Abstract][Full Text] [Related]
16. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.
Nagai E; Ueyama T; Yao T; Tsuneyoshi M
Cancer; 1993 Sep; 72(6):1827-35. PubMed ID: 7689918
[TBL] [Abstract][Full Text] [Related]
17. [Histopathological and immunohistochemical studies in hepatoid adenocarcinomas of the stomach].
Li X; Zhang D; Le M
Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):276-9. PubMed ID: 9388871
[TBL] [Abstract][Full Text] [Related]
18. [AFP-producing gastric cancer and hepatoid gastric cancer].
Wang YK; Zhang XT
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):801-807. PubMed ID: 29151285
[TBL] [Abstract][Full Text] [Related]
19. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma).
Roberts CC; Colby TV; Batts KP
Mayo Clin Proc; 1997 Dec; 72(12):1154-60. PubMed ID: 9413299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
